Recombinant Human PGGT1b Protein，His

PGGT1b, or protein geranylgeranyltransferase type I beta, is an enzyme that plays a crucial role in the post-translational modification of proteins through the addition of geranylgeranyl groups. This modification is vital for the proper membrane localization and function of various signaling proteins, including many small GTPases that are involved in cell growth, differentiation, and survival. The dysregulation of PGGT1b and the pathways it influences has been implicated in several diseases, particularly cancer, where aberrant protein localization can lead to uncontrolled cell proliferation and tumor progression. Research on PGGT1b recombinant protein has gained significant attention due to its potential as a therapeutic target in malignancies driven by altered signaling pathways. By studying the structure-function relationship of PGGT1b, scientists aim to develop inhibitors that can specifically disrupt its activity, thereby providing a novel approach to more effective cancer treatments. Furthermore, understanding the enzymatic mechanism and substrate specificity of PGGT1b offers insights into the broader family of prenyltransferases and their roles in other diseases, including cardiovascular disorders and neurodegenerative conditions. Overall, the continued investigation of PGGT1b and its recombinant forms is essential for unraveling its complex biological functions and advancing potential clinical applications.